Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Shenzhen - Delayed Quote CNY

Hangzhou Coco Healthcare Products Co.,Ltd. (301009.SZ)

Compare
11.09
+0.07
+(0.64%)
At close: April 3 at 3:04:10 PM GMT+8
Loading Chart for 301009.SZ
  • Previous Close 11.02
  • Open 12.68
  • Bid 11.08 x --
  • Ask 11.09 x --
  • Day's Range 10.87 - 11.15
  • 52 Week Range 6.81 - 14.83
  • Volume 4,000,200
  • Avg. Volume 10,402,387
  • Market Cap (intraday) 3.015B
  • Beta (5Y Monthly) 0.77
  • PE Ratio (TTM) 221.80
  • EPS (TTM) 0.05
  • Earnings Date --
  • Forward Dividend & Yield 0.08 (0.68%)
  • Ex-Dividend Date Jul 19, 2024
  • 1y Target Est --

Hangzhou Coco Healthcare Products Co.,Ltd. engages in the research, development, production, and sale of baby care, adult incontinence, and pet care products in China. It offers adult incontinence products, including adult diapers, adult pull-up pants, nursing pads, maternity towels, menstrual pants, absorbent towels, and other products, as well as absorbent towels and absorbent pads for men. The company was formerly known as Hangzhou Qiaozi Paper Industry Co.,Ltd. and changed its name to Hangzhou Coco Healthcare Products Co.,Ltd. in December 2011. Hangzhou Coco Healthcare Products Co.,Ltd. was founded in 2001 and is based in Hangzhou, China.

www.cocohealthcare.com

614

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 301009.SZ

View More

Performance Overview: 301009.SZ

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

301009.SZ
3.74%
SSE Composite Index (000001.SS)
0.29%

1-Year Return

301009.SZ
22.06%
SSE Composite Index (000001.SS)
8.89%

3-Year Return

301009.SZ
24.32%
SSE Composite Index (000001.SS)
1.81%

5-Year Return

301009.SZ
63.03%
SSE Composite Index (000001.SS)
20.91%

Compare To: 301009.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 301009.SZ

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    3.01B

  • Enterprise Value

    2.26B

  • Trailing P/E

    214.09

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.99

  • Price/Book (mrq)

    2.24

  • Enterprise Value/Revenue

    2.12

  • Enterprise Value/EBITDA

    131.94

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.41%

  • Return on Assets (ttm)

    -0.02%

  • Return on Equity (ttm)

    0.97%

  • Revenue (ttm)

    1.06B

  • Net Income Avi to Common (ttm)

    15.05M

  • Diluted EPS (ttm)

    0.05

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    768.4M

  • Total Debt/Equity (mrq)

    0.92%

  • Levered Free Cash Flow (ttm)

    -5.83M

Research Analysis: 301009.SZ

View More

Company Insights: 301009.SZ

Research Reports: 301009.SZ

View More

People Also Watch